Massachusetts Life Science M&A Hits $22.5 Billion So Far This YearAllbiopro2019-07-11T08:36:09+09:007월 11th, 2019|
Novartis amps up Symjepi launch to fill Pfizer’s EpiPen supply gapAllbiopro2019-07-11T08:35:37+09:007월 11th, 2019|
Warning letter faults Akorn management for plant failuresAllbiopro2019-07-11T08:35:05+09:007월 11th, 2019|
FDA promises ‘elevated’ new drug approvals, but warns of potential pitfalls: reportAllbiopro2019-07-11T08:34:37+09:007월 11th, 2019|
Score! ‘Good Pharma’ ranking finds uptick in new drug data sharing and clinical trial transparencyAllbiopro2019-07-11T08:34:02+09:007월 11th, 2019|
GSK touts new Dovato switching data. Is it enough to shake Gilead’s HIV lead?Allbiopro2019-07-11T08:33:28+09:007월 11th, 2019|
Osivax raises €8M for universal flu vaccine clinical trialsAllbiopro2019-07-11T08:32:55+09:007월 11th, 2019|
Revolution Medicines snags $100M to attack RAS-mutated cancersAllbiopro2019-07-11T08:32:22+09:007월 11th, 2019|
FDA accepts BLA filing for Sanofi’s rival to J&J’s Darzalex Allbiopro2019-07-11T08:31:51+09:007월 11th, 2019|
Charles River plots 2020 opening of South San Francisco labAllbiopro2019-07-11T08:31:19+09:007월 11th, 2019|
After exiting troubled Merrimack, former CEO becomes new chief at YumanityAllbiopro2019-07-11T08:30:46+09:007월 11th, 2019|
Single-use techs are garbage, eventually, and that’s great for biopharmaAllbiopro2019-07-11T08:29:42+09:007월 11th, 2019|
Investment digest: News from Pfizer, Bayer and AltimmuneAllbiopro2019-07-11T08:29:09+09:007월 11th, 2019|
Algal biomass as a raw material for fermentations and for the isolation of valuable sugarsAllbiopro2019-07-11T08:28:09+09:007월 11th, 2019|
MorphoSys and Vivoryon Therapeutics Enter Agreement in Immuno-OncologyAllbiopro2019-07-11T08:27:37+09:007월 11th, 2019|
